Poisoning
Showing 9976 - 10000 of >10,000
Hepatitis B Trial in Grafton (ARC-521 Injection, Placebo, antihistamine)
Terminated
- Hepatitis B
- ARC-521 Injection
- +5 more
-
Grafton, Auckland, New ZealandAuckland Clinical Studies Ltd
Jan 10, 2018
Alzheimer's Disease Trial (Verubecestat (Part I and Part II), Placebo (Part I), Verubecestat (Part II))
Terminated
- Alzheimer's Disease
- Verubecestat (Part I and Part II)
- +2 more
- (no location specified)
Sep 24, 2018
Dentine Sensitivity Trial in Ellesmere Port, Maldon, Wirral (Calcium sodium phosphosilicate, Sodium fluoride, Sodium
Completed
- Dentine Sensitivity
- Calcium sodium phosphosilicate
- +2 more
-
Ellesmere Port, Cheshire, United Kingdom
- +2 more
Mar 9, 2018
Arthritis, Rheumatoid Trial in Worldwide (Sirukumab 100 mg, Sirukumab 50 mg, Placebo)
Completed
- Arthritis, Rheumatoid
- Sirukumab 100 mg
- +2 more
-
Birmingham, Alabama
- +200 more
Apr 12, 2019
Adult Primary Liver Cancer, Hepatitis C Infection Trial in United States (S-adenosyl-L-methionine disulfate p-toluene-sulfonate,
Completed
- Adult Primary Liver Cancer
- Hepatitis C Infection
- S-adenosyl-L-methionine disulfate p-toluene-sulfonate
- +4 more
-
Tucson, Arizona
- +4 more
Aug 9, 2018
Depressive Disorder, Major Trial in Japan, Korea, Republic of (323U66 SR 150 mg tablet, 323U66 SR 150 mg tablet)
Completed
- Depressive Disorder, Major
- 323U66 SR 150 mg tablet
- 323U66 SR 150 mg placebo tablet
-
Aichi, Japan
- +58 more
Jun 18, 2018
Rhinoconjunctivitis Trial in Worldwide (Cat-PAD, Placebo)
Completed
- Rhinoconjunctivitis
- Cat-PAD
- Placebo
-
Rolling Hills Estates, California
- +117 more
May 16, 2018
Pulmonary Disease, Chronic Obstructive Trial in Canada, United States (simvastatin, Placebo)
Terminated
- Pulmonary Disease, Chronic Obstructive
- simvastatin
- Placebo
-
Birmingham, Alabama
- +50 more
Dec 8, 2017
Solid Tumors Trial in New Brunswick (LY573636, Pemetrexed)
Completed
- Solid Tumors
-
New Brunswick, New JerseyFor additional information regarding investigative sites for thi
Dec 1, 2018
Multiple Myeloma Trial in Worldwide (pomalidomide, Dexamethasone)
Completed
- Multiple Myeloma
-
Rochester, Minnesota
- +93 more
Sep 25, 2018
Acute Respiratory Distress Syndrome Trial in Warrington (A.1 Lucinactant, B.3 SoC, A.2 Lucinactant)
Terminated
- Acute Respiratory Distress Syndrome
- A.1 Lucinactant
- +6 more
-
Warrington, PennsylvaniaDiscovery Laboratories, Inc.
Jul 12, 2018
Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Neratinib, Lapatinib, Capecitabine)
Completed
- Advanced Breast Cancer
- Breast Cancer
- Neratinib
- +2 more
-
Tucson, Arizona
- +151 more
Jul 11, 2018
Prostate Cancer Trial in United States (Control, Sipuleucel-T)
Completed
- Prostate Cancer
- Control
- Sipuleucel-T
-
Berkeley, California
- +17 more
Jun 29, 2017
Rheumatoid Arthritis Trial in United States (Certolizumab Pegol (CZP))
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol (CZP)
-
Birmingham, Alabama
- +109 more
Jul 4, 2018
Tumors, Breast Cancer Trial in United States (PF-06650808)
Terminated
- Neoplasms
- Breast Cancer
-
Los Angeles, California
- +10 more
Dec 21, 2018
Idiopathic Pulmonary Fibrosis Trial in Worldwide (Lebrikizumab, Pirfenidone, Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- Lebrikizumab
- +2 more
-
Birmingham, Alabama
- +111 more
Aug 22, 2018
Carcinoid Syndrome Trial in United States (Telotristat etiprate, Octreotide LAR Depot, Placebo)
Completed
- Carcinoid Syndrome
- Telotristat etiprate
- +2 more
-
Little Rock, Arkansas
- +8 more
Dec 3, 2018
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Fluticasone Furoate 100mcg/ GW642444 (vilanterol) 25mcg, Fluticasone
Completed
- Pulmonary Disease, Chronic Obstructive
- Fluticasone Furoate 100mcg/ GW642444 (vilanterol) 25mcg
- +3 more
-
Jasper, Alabama
- +50 more
Jan 18, 2018
Infection, Human Immunodeficiency Virus Trial in Worldwide (BMS-663068 400 mg, BMS-663068 800 mg, BMS-663068 600 mg)
Completed
- Infection, Human Immunodeficiency Virus
- BMS-663068 400 mg
- +7 more
-
San Francisco, California
- +55 more
Oct 16, 2018